Health & Fitness
Lexington Vaccine Company Cites Antibody Response
An experimental coronavirus vaccine developed by Translate Bio showed high levels of antibodies in animal tests.
LEXINGTON, MA — Lexington-based Translate Bio inc. developed an experimental coronavirus vaccine with the French vaccine company Sanofi, and the vaccine is showing high levels of antibodies in early-stage animal studies, according to a regulatory filing obtained by Bloomberg news.
Translate Bio is an mRNA therapeutics company partnering with Saofi for the COVID-19 vaccine work — according to Bloomberg news, who broke the story, Sanofi was set to present the data at an event on Tuesday.
Read more about this story at Bloomberg News.
Find out what's happening in Lexingtonfor free with the latest updates from Patch.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.